SCOPE 2024 - a great place to hear best practice and move the needle for life sciences
Veeva’s Jim Reilly, vice president is Veeva Development Cloud strategy and along with countless others is getting excited about SCOPE 2024.
Archives for January 24, 2024
SCOPE 2024
Pharma at a critical crossroads in approach bringing new medicines to market, says OM1's CCO
OM1 says it wants to stand at the helm of a healthcare revolution, fostering an integrated approach to generating and utilizing real-world evidence (RWE), reshaping the foundation of healthcare.
SCOPE 2024
SCOPE - the go-to destination for sharing innovative approaches in clinical operation
Dawn Kaminski is vice president, of business development (BD) operations at eClinical Solutions and is responsible for working with the BD team as a subject matter expert for services and technology, strategically positioning the organization to acquire...
SCOPE 2024
SCOPE - first-hand insights from experts at the forefront of the industry
Medable says its mission is to get effective therapies to patients faster.
Women in Science: Colleen Acosta - from star gazing to reproductive health and the microbiome
Colleen Acosta is CEO of Freya Biosciences which is a trans-Atlantic clinical-stage biotech company pioneering microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of women’s reproductive system conditions and we were...
SCOPE 2024
Advarra at SCOPE - excited to hear about site and sponsor technology coordination
Elisa Cascade is chief product officer at Advarra, a business that says it aims to advance the way clinical research is conducted by bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of...
Attending SCOPE - important to understand the latest trends in clinical research
Curavit prides itself as the first ‘all-virtual CRO’ that designs and executes decentralized clinical trials – also known as virtual trials.
Bridging the gap between the promise of technology and reality - Lokavant's hopes for SCOPE
Andrew Mills, executive vice president of global commercial Lokavant and says the company can help businesses identify risk trends in trials much earlier than traditional methods.
Lightship's hopes for SCOPE 2024 - AI and tech in clinical trials creating the buzz
Sepehr Shojaei serves as the vice president of design solutions at Lightship, using his 15 years of experience in clinical research operations to champion a patient-centric approach.
SCOPE 2024 - Mural Health keen to focus on patient centricity and diversity
Sam Whitaker is co-CEO and co-founder at Mural Health.